PHASQ / PhaseBio Pharmaceuticals, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

PhaseBio Pharmaceuticals, Inc.
US ˙ OTCPK ˙ US7172241090
DENNA SYMBOL ÄR INTE LÄNGRE AKTIV

Insideraktier12 488 536 shares
Insider Sentiment Score

Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.

Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.

Uppdateringsfrekvens: Dagligen

Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.

Office Sentiment Score

Officersentiment Score hittar företag som köps av Corporate Officers.

Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.

Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.

Uppdateringsfrekvens: Dagligen

Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.

Viktiga insidernyckeltal

Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.

Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).

Nettoantalet insiders som köper (rankning)

N/A

Nettoantalet insiders som köper är den totala mängden insiders som säljer minus det totala antalet insiders som säljer under de senaste 90 dagarna. Percentilrankningen visas här (intervall från 0 till 100%).

Procent av flytande köpta av insiders (ranking)

N/A

Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.

Insiderhandelsdiagram

PhaseBio Pharmaceuticals, Inc. insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.

Insiderlista och lönsamhetsstatistik

Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.

See our leaderboard of most profitable insider traders.

Insider Genomsnitt vinst (%) Aktier
Ägda
Delad
Justerad

Report errors via our new Insider Auditing Tool

Track Records av insiderköp - Kortsiktig vinstanalys

I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i PHASQ / PhaseBio Pharmaceuticals, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .

Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.

Handelsdatum Insider Rapporterade
aktier
Rapporterat
pris
Justerade
aktier
Justerat
pris
Kostnadsbasis Dagar til
Max
Pris vid
Max
Maximal
vinst ($)
Maximal avkastning (%)
2021-08-18 Thorp Clay 10 000 3,0000 10 000 3,0000 30 000 76 4.05 10 500 35,00
2021-08-18 Hutson Nancy J 3 000 3,0800 3 000 3,0800 9 240
2020-12-03 HARRIGAN EDMUND 6 000 4,1200 6 000 4,1200 24 720
2020-11-24 Thorp Clay 2 000 3,5000 2 000 3,5000 7 000
2020-11-23 Thorp Clay 3 000 3,6700 3 000 3,6700 11 010
2018-12-17 Hutson Nancy J 1 000 4,4600 1 000 4,4600 4 460
2018-12-13 Ballance David James 1 000 3,9400 1 000 3,9400 3 940
2018-12-13 Mow Jonathan P 1 000 3,6900 1 000 3,6900 3 690
2018-12-11 York Michael 1 500 3,8800 1 500 3,8800 5 820

Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.

PHASQ / PhaseBio Pharmaceuticals, Inc. Insider Trades
Track Records av insiderförsäljning - Kortsiktig förlustanalys

I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i PHASQ / PhaseBio Pharmaceuticals, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .

Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.

Handelsdatum Insider Rapporterade
aktier
Rapporterat
pris
Justerade
aktier
Justerat
pris
Kostnadsbasis Dagar til
Min
Pris vid
Min
Maximal förlust
undvikits ($)
Maximal förlust
undvikits ($)
2022-10-25 NEW ENTERPRISE ASSOCIATES 13 LP 1 784 109 0,1470 1 784 109 0,1470 262 264 8 0.0701 −137 198 −52,31
2021-05-20 Burkhardt Glen 3 811 3,2900 3 811 3,2900 12 538
2020-11-23 Burkhardt Glen 3 497 3,4500 3 497 3,4500 12 065

Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.

PHASQ / PhaseBio Pharmaceuticals, Inc. Insider Trades
Transaktionshistorik

Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.

Fil
datum
Handel
datum
Schema Insider Ticker Värdepappertitel Kod 10b5-1 Direkta Utövningspris Enhet
pris
Enheter
ändrad
Värde
ändrad (1K)
Kvarvarande
Optioner
Kvarvarande
Aktier
2023-05-19 2023-05-19 4 Humphries William D. PHAS Common Stock M - Exercise D 2 538 2 538
2023-05-19 2023-05-19 4 Thorp Clay PHAS Common Stock M - Exercise D 3 750 36 693
2023-05-19 2023-05-19 4 van den Broek Richard PHAS Common Stock A - Award D 3 750 0
2023-05-19 2023-05-19 4 Loewy Caroline M PHAS Common Stock M - Exercise D 3 750 3 750
2023-05-19 2023-05-19 4 Sapir Alex PHAS Common Stock M - Exercise D 3 750 3 750
2023-05-19 2023-05-19 4 HARRIGAN EDMUND PHAS Common Stock M - Exercise D 3 750 9 750
2023-05-19 2023-05-19 4 Hutson Nancy J PHAS Common Stock M - Exercise D 3 750 37 510
2022-10-26 2022-10-25 4 NEW ENTERPRISE ASSOCIATES 13 LP PHAS Common Stock S - Sale D 0,1470 −1 784 109 −262 4 857 525
2022-05-24 2022-05-20 4 Arnold Susan Elizabeth PHAS Common Stock A - Award D 0,6813 10 917 7 41 236
2022-05-24 2022-05-20 4 Mow Jonathan P PHAS Common Stock A - Award D 0,6813 10 918 7 132 502
2022-05-24 2022-05-20 4 Hanson Kristopher PHAS Common Stock A - Award D 0,6813 4 831 3 8 463
2022-05-24 2022-05-20 4 Birchall Jonathan PHAS Common Stock A - Award D 0,6813 20 000 14 20 000
2022-05-24 2022-05-23 4 Burkhardt Glen PHAS Common Stock S - Sale D 0,7900 −11 248 −9 0
2022-05-24 2022-05-20 4 Burkhardt Glen PHAS Common Stock A - Award D 0,6813 11 248 8 11 248
2022-05-24 2022-05-20 4 Sharp John P PHAS Common Stock A - Award D 0,6813 6 026 4 65 767
2022-05-20 2021-08-18 4/A Hutson Nancy J Held in an individual retirement account for the benefit of the Reporting Person PHAS Common Stock P - Purchase I 3,0800 3 000 9 4 000
2022-05-20 2022-05-19 4 Thorp Clay PHAS Restricted Stock Units A - Award D 3 750 3 750
2022-05-20 2022-05-19 4 Thorp Clay PHAS Non-employee Director Stock Option (right to buy) A - Award D 0,84 17 500 17 500
2022-05-20 2022-05-19 4 Humphries William D. PHAS Restricted Stock Units A - Award D 3 750 3 750
2022-05-20 2022-05-19 4 Humphries William D. PHAS Non-employee Director Stock Option (right to buy) A - Award D 0,84 17 500 17 500
2022-05-20 2022-05-19 4 Loewy Caroline M PHAS Restricted Stock Units A - Award D 3 750 3 750
2022-05-20 2022-05-19 4 Loewy Caroline M PHAS Non-employee Director Stock Option (right to buy) A - Award D 0,84 17 500 17 500
2022-05-20 2022-05-19 4 Sapir Alex PHAS Restricted Stock Units A - Award D 3 750 3 750
2022-05-20 2022-05-19 4 Sapir Alex PHAS Non-employee Director Stock Option (right to buy) A - Award D 0,84 17 500 17 500
2022-05-20 2022-05-19 4 Hutson Nancy J PHAS Restricted Stock Units A - Award D 3 750 3 750
2022-05-20 2022-05-19 4 Hutson Nancy J PHAS Non-employee Director Stock Option (right to buy) A - Award D 0,84 17 500 17 500
2022-05-20 2022-05-19 4 van den Broek Richard PHAS Restricted Stock Units A - Award D 3 750 3 750
2022-05-20 2022-05-19 4 van den Broek Richard PHAS Non-employee Director Stock Option (right to buy) A - Award D 0,84 17 500 17 500
2022-05-20 2022-05-19 4 HARRIGAN EDMUND PHAS Restricted Stock Units A - Award D 3 750 3 750
2022-05-20 2022-05-19 4 HARRIGAN EDMUND PHAS Non-employee Director Stock Option (right to buy) A - Award D 0,84 17 500 17 500
2022-02-28 2022-02-24 4 Burkhardt Glen PHAS Employee Stock Option (right to buy) A - Award D 1,13 87 500 87 500
2022-02-28 2022-02-24 4 Burkhardt Glen PHAS Restricted Stock Unit A - Award D 18 750 18 750
2022-02-28 2022-02-24 4 Sharp John P PHAS Employee Stock Option (right to buy) A - Award D 1,13 115 500 115 500
2022-02-28 2022-02-24 4 Sharp John P PHAS Restricted Stock Unit A - Award D 24 750 24 750
2022-02-28 2022-02-24 4 Birchall Jonathan PHAS Employee Stock Option (right to buy) A - Award D 1,13 52 500 52 500
2022-02-28 2022-02-24 4 Birchall Jonathan PHAS Restricted Stock Unit A - Award D 11 250 11 250
2022-02-28 2022-02-24 4 Arnold Susan Elizabeth PHAS Employee Stock Option (right to buy) A - Award D 1,13 87 500 87 500
2022-02-28 2022-02-24 4 Arnold Susan Elizabeth PHAS Restricted Stock Unit A - Award D 18 750 18 750
2022-02-28 2022-02-24 4 Lee John Sang PHAS Employee Stock Option (right to buy) A - Award D 1,13 115 500 115 500
2022-02-28 2022-02-24 4 Lee John Sang PHAS Restricted Stock Unit A - Award D 24 750 24 750
2022-02-28 2022-02-24 4 Mow Jonathan P PHAS Employee Stock Option (right to buy) A - Award D 1,13 385 000 385 000
2022-02-28 2022-02-24 4 Mow Jonathan P PHAS Restricted Stock Unit A - Award D 82 500 82 500
2022-02-28 2022-02-24 4 Hanson Kristopher PHAS Employee Stock Option (right to buy) A - Award D 1,13 87 500 87 500
2022-02-28 2022-02-24 4 Hanson Kristopher PHAS Restricted Stock Unit A - Award D 18 750 18 750
2021-11-23 2021-11-19 4 Arnold Susan Elizabeth PHAS Common Stock A - Award D 2,0100 2 559 5 30 319
2021-11-23 2021-11-19 4 Mow Jonathan P PHAS Common Stock A - Award D 2,0100 5 623 11 172 473
2021-11-23 2021-11-19 4 Sharp John P PHAS Common Stock A - Award D 2,0100 2 017 4 59 741
2021-11-23 2021-11-19 4 Hanson Kristopher PHAS Common Stock A - Award D 2,0100 1 545 3 3 632
2021-11-23 2021-11-19 4 Burkhardt Glen PHAS Common Stock S - Sale D 2,3700 −5 766 −14 0
2021-11-23 2021-11-19 4 Burkhardt Glen PHAS Common Stock A - Award D 2,0100 5 766 12 5 766
2021-11-09 2021-11-08 4 Birchall Jonathan PHAS Employee Stock Option (right to buy) A - Award D 3,37 3,3700 250 000 842 250 000
2021-11-08 2021-11-08 4 Hutson Nancy J PHAS Non-employee Director Stock Option (right to buy) M - Exercise D 3,15 3,1500 −7 400 −23 0
2021-11-08 2021-11-08 4 Hutson Nancy J PHAS Common Stock M - Exercise D 3,1500 7 400 23 33 760
2021-11-08 2021-11-05 4 Hutson Nancy J PHAS Non-employee Director Stock Option (right to buy) M - Exercise D 3,15 3,1500 −1 500 −5 7 400
2021-11-08 2021-11-05 4 Hutson Nancy J PHAS Non-employee Director Stock Option (right to buy) M - Exercise D 2,26 2,2600 −24 860 −56 2 256
2021-11-08 2021-11-05 4 Hutson Nancy J PHAS Common Stock M - Exercise D 3,1500 1 500 5 26 360
2021-11-08 2021-11-05 4 Hutson Nancy J PHAS Common Stock M - Exercise D 2,2600 24 860 56 24 860
2021-11-03 2021-11-03 4 Sharp John P PHAS Employee Stock Option (right to buy) M - Exercise D 1,68 1,6800 −7 500 −13 90 582
2021-11-03 2021-11-03 4 Sharp John P PHAS Common Stock M - Exercise D 1,6800 7 500 13 57 724
2021-11-03 2021-11-03 4 Mow Jonathan P PHAS Employee Stock Option (right to buy) M - Exercise D 1,24 1,2400 −20 000 −25 108 767
2021-11-03 2021-11-03 4 Mow Jonathan P PHAS Common Stock M - Exercise D 1,2400 20 000 25 166 850
2021-09-15 2021-09-14 4 Humphries William D. PHAS Non-employee Director Stock Option (right to buy) A - Award D 2,80 28 000 28 000
2021-09-03 2021-07-12 4/A Arnold Susan Elizabeth PHAS Employee Stock Option (right to buy) M - Exercise D 1,74 −4 519 0
2021-09-03 2021-07-12 4/A Arnold Susan Elizabeth PHAS Common Stock M - Exercise D 1,7400 4 519 8 27 760
2021-09-03 2021-08-03 4/A Sharp John P PHAS Employee Stock Option (right to buy) M - Exercise D 1,68 −7 500 98 082
2021-09-03 2021-08-03 4/A Sharp John P PHAS Common Stock M - Exercise D 1,6800 7 500 13 50 224
2021-08-30 2021-08-27 4 Mow Jonathan P PHAS Employee Stock Option (right to buy) M - Exercise D 1,24 −20 000 128 767
2021-08-30 2021-08-27 4 Mow Jonathan P PHAS Common Stock M - Exercise D 1,2400 20 000 25 146 850
2021-08-19 2021-08-18 4 Hutson Nancy J Held in an individual retirement account for the benefit of the reporting person PHAS Common Stock P - Purchase I 3,0800 3 000 9 4 000
2021-08-18 2021-08-18 4 Thorp Clay PHAS Common Stock P - Purchase D 3,0000 10 000 30 32 943
2021-08-04 2021-08-03 4 Sharp John P PHAS Common Stock A - Award D 1,6800 7 500 13 50 224
2021-07-14 2021-07-12 4 Arnold Susan Elizabeth PHAS Common Stock A - Award D 1,7400 4 519 8 27 760
2021-06-04 2021-06-03 4 van den Broek Richard PHAS Non-employee Director Stock Option (right to buy) A - Award D 3,53 14 000 14 000
2021-06-04 2021-06-03 4 Sapir Alex PHAS Non-employee Director Stock Option (right to buy) A - Award D 3,53 14 000 14 000
2021-06-04 2021-06-03 4 HARRIGAN EDMUND PHAS Non-employee Director Stock Option (right to buy) A - Award D 3,53 14 000 14 000
2021-06-04 2021-06-03 4 Klein Peter Justin PHAS Non-employee Director Stock Option (right to buy) A - Award D 3,53 14 000 14 000
2021-06-04 2021-06-03 4 Loewy Caroline M PHAS Non-employee Director Stock Option (right to buy) A - Award D 3,53 14 000 14 000
2021-06-04 2021-06-03 4 Hutson Nancy J PHAS Non-employee Director Stock Option (right to buy) A - Award D 3,53 14 000 14 000
2021-06-04 2021-06-03 4 Thorp Clay PHAS Non-employee Director Stock Option (right to buy) A - Award D 3,53 14 000 14 000
2021-05-24 2021-05-20 4 Arnold Susan Elizabeth PHAS Common Stock A - Award D 2,8000 5 257 15 23 241
2021-05-24 2021-05-20 4 York Michael PHAS Common Stock A - Award D 2,8000 2 897 8 7 059
2021-05-24 2021-05-20 4 Hanson Kristopher PHAS Common Stock A - Award D 2,8000 1 088 3 2 087
2021-05-24 2021-05-20 4 Mow Jonathan P PHAS Common Stock A - Award D 2,8000 3 964 11 126 850
2021-05-24 2021-05-20 4 Burkhardt Glen PHAS Common Stock S - Sale D 3,2900 −3 811 −13 0
2021-05-24 2021-05-20 4 Burkhardt Glen PHAS Common Stock A - Award D 2,8000 3 811 11 3 811
2021-05-24 2021-05-20 4 Sharp John P PHAS Common Stock A - Award D 2,8000 1 419 4 42 724
2021-02-09 2021-02-05 4 Mow Jonathan P PHAS Employee Stock Option (right to buy) A - Award D 4,31 234 000 234 000
2021-02-09 2021-02-05 4 Hanson Kristopher PHAS Employee Stock Option (right to buy) A - Award D 4,31 36 000 36 000
2021-02-09 2021-02-05 4 York Michael PHAS Employee Stock Option (right to buy) A - Award D 4,31 36 000 36 000
2021-02-09 2021-02-05 4 Arnold Susan Elizabeth PHAS Employee Stock Option (right to buy) A - Award D 4,31 36 000 36 000
2021-02-09 2021-02-05 4 Sharp John P PHAS Employee Stock Option (right to buy) A - Award D 4,31 76 500 76 500
2021-02-09 2021-02-05 4 Lee John Sang PHAS Employee Stock Option (right to buy) A - Award D 4,31 76 500 76 500
2021-02-09 2021-02-05 4 Burkhardt Glen PHAS Employee Stock Option (right to buy) A - Award D 4,31 36 000 36 000
2020-12-04 2020-12-03 4 HARRIGAN EDMUND PHAS Common Stock P - Purchase D 4,1200 6 000 25 6 000
2020-11-24 2020-11-24 4 Thorp Clay PHAS Common Stock P - Purchase D 3,5000 2 000 7 22 943
2020-11-24 2020-11-23 4 Thorp Clay PHAS Common Stock P - Purchase D 3,6700 3 000 11 20 943
2020-11-23 2020-11-20 4 Sharp John P PHAS Common Stock A - Award D 3,0000 1 305 4 41 305
2020-11-23 2020-11-20 4 Hanson Kristopher PHAS Common Stock A - Award D 3,0000 999 3 999
2020-11-23 2020-11-20 4 York Michael PHAS Common Stock A - Award D 3,0000 2 662 8 4 162
2020-11-23 2020-11-20 4 Ballance David James PHAS Common Stock A - Award D 3,0000 919 3 8 519
2020-11-23 2020-11-20 4 Mow Jonathan P PHAS Common Stock A - Award D 3,0000 3 643 11 122 886
2020-11-23 2020-11-20 4 Arnold Susan Elizabeth PHAS Common Stock A - Award D 3,0000 4 832 14 17 984
2020-11-23 2020-11-23 4 Burkhardt Glen PHAS Common Stock S - Sale D 3,4500 −3 497 −12 0
2020-11-23 2020-11-20 4 Burkhardt Glen PHAS Common Stock A - Award D 3,0000 3 497 10 3 497
2020-11-18 2020-11-16 4 Thorp Clay By Catalysta Ventures, LLC PHAS Common Stock J - Other I 10 586 15 432
2020-11-18 2020-11-16 4 Thorp Clay PHAS Common Stock J - Other D 2 144 17 943
2020-11-18 2020-11-16 4 Thorp Clay By Hatteras Venture Partners I, LP PHAS Common Stock J - Other I −52 397 0
2020-10-05 2020-10-01 4 Arnold Susan Elizabeth PHAS Employee Stock Option (right to buy) M - Exercise D 1,15 1,1500 −5 423 −6 0
2020-10-05 2020-10-01 4 Arnold Susan Elizabeth PHAS Common Stock M - Exercise D 1,1500 5 423 6 13 152
2020-10-05 2020-02-27 4 Arnold Susan Elizabeth PHAS Employee Stock Option (right to buy) M - Exercise D 1,15 1,1500 −5 423 −6 0
2020-10-05 2020-02-27 4 Arnold Susan Elizabeth PHAS Common Stock M - Exercise D 1,1500 5 423 6 7 729
2020-08-24 2020-08-21 4 Mow Jonathan P PHAS Employee Stock Option (right to buy) M - Exercise D 1,24 −10 000 148 767
2020-08-24 2020-08-21 4 Mow Jonathan P PHAS Common Stock M - Exercise D 1,2400 10 000 12 119 243
2020-08-17 2020-08-14 4 Sharp John P PHAS Employee Stock Option (right to buy) M - Exercise D 1,69 −5 000 105 582
2020-08-17 2020-08-14 4 Sharp John P PHAS Common Stock M - Exercise D 1,6900 5 000 8 40 000
2020-06-05 2020-06-03 4 Sapir Alex PHAS Non-employee Director Stock Option (right to buy) A - Award D 4,86 4 909 4 909
2020-06-05 2020-06-03 4 Loewy Caroline M PHAS Non-employee Director Stock Option (right to buy) A - Award D 0,00 16 000 16 000
2020-06-05 2020-06-03 4 HARRIGAN EDMUND PHAS Non-employee Director Stock Option (right to buy) A - Award D 4,86 16 000 16 000
2020-06-05 2020-06-03 4 Hutson Nancy J PHAS Non-employee Director Stock Option (right to buy) A - Award D 4,86 16 000 16 000
2020-06-05 2020-06-03 4 van den Broek Richard PHAS Non-employee Director Stock Option (right to buy) A - Award D 4,86 16 000 16 000
2020-06-05 2020-06-03 4 Klein Peter Justin PHAS Non-employee Director Stock Option (right to buy) A - Award D 4,86 16 000 16 000
2020-06-05 2020-06-03 4 Thorp Clay PHAS Non-employee Director Stock Option (right to buy) A - Award D 4,86 16 000 16 000
2020-02-14 2020-02-12 4 Burkhardt Glen PHAS Employee Stock Option (right to buy) A - Award D 5,19 20 000 20 000
2020-02-14 2020-02-12 4 Burkhardt Glen PHAS Employee Stock Option (right to buy) A - Award D 5,19 55 000 55 000
2020-02-14 2020-02-12 4 York Michael PHAS Employee Stock Option (right to buy) A - Award D 5,19 55 000 55 000
2020-02-14 2020-02-12 4 Sharp John P PHAS Employee Stock Option (right to buy) A - Award D 5,19 100 000 100 000
2020-02-14 2020-02-12 4 Hanson Kristopher PHAS Employee Stock Option (right to buy) A - Award D 5,19 55 000 55 000
2020-02-14 2020-02-12 4 Sapir Alex PHAS Employee Stock Option (right to buy) A - Award D 5,19 32 000 32 000
2020-02-14 2020-02-12 4 Lee John Sang PHAS Employee Stock Option (right to buy) A - Award D 5,19 100 000 100 000
2020-02-14 2020-02-12 4 Arnold Susan Elizabeth PHAS Employee Stock Option (right to buy) A - Award D 5,19 55 000 55 000
2020-02-14 2020-02-12 4 Ballance David James PHAS Employee Stock Option (right to buy) A - Award D 5,19 55 000 55 000
2020-02-14 2020-02-12 4 Mow Jonathan P PHAS Employee Stock Option (right to buy) A - Award D 5,19 290 000 290 000
2019-10-07 2019-10-07 4 Hanson Kristopher PHAS Employee Stock Option (right to buy) A - Award D 4,17 66 000 66 000
2019-09-10 2019-09-06 4 Mow Jonathan P PHAS Employee Stock Option (right to buy) M - Exercise D 1,24 −19 000 158 767
2019-09-10 2019-09-06 4 Mow Jonathan P PHAS Common Stock M - Exercise D 1,2400 19 000 24 109 243
2019-08-22 2019-08-21 4 Sharp John P PHAS Employee Stock Option (right to buy) M - Exercise D 1,44 −5 000 4 038
2019-08-22 2019-08-21 4 Sharp John P PHAS Employee Stock Option (right to buy) M - Exercise D 1,69 −10 000 110 582
2019-08-22 2019-08-21 4 Sharp John P PHAS Common Stock M - Exercise D 1,4400 5 000 7 35 000
2019-08-22 2019-08-21 4 Sharp John P PHAS Common Stock M - Exercise D 1,6900 10 000 17 30 000
2019-07-03 2019-07-01 4 Thorp Clay By Venture Capital Multiplier Fund PHAS Common Stock S - Sale I 14,0000 −459 −6 415 959
2019-07-03 2019-07-01 4 Thorp Clay By Hatteras Venture Partners I, LP PHAS Common Stock S - Sale I 14,0000 −255 −4 52 397
2019-07-03 2019-07-01 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Common Stock S - Sale I 14,0000 −180 −3 162 890
2019-07-03 2019-07-01 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Common Stock S - Sale I 14,0000 −2 014 −28 1 818 638
2019-06-20 2019-06-18 4 Thorp Clay By Venture Capital Multiplier Fund PHAS Common Stock S - Sale I 14,0000 −63 −1 416 418
2019-06-20 2019-06-18 4 Thorp Clay By Hatteras Venture Partners I, LP PHAS Common Stock S - Sale I 14,0000 −35 −0 52 655
2019-06-20 2019-06-18 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Common Stock S - Sale I 14,0000 −25 −0 163 074
2019-06-20 2019-06-18 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Common Stock S - Sale I 14,0000 −277 −4 1 820 656
2019-05-24 2019-05-22 4 Sharp John P PHAS Employee Stock Option (right to buy) M - Exercise D 1,69 −15 000 120 582
2019-05-24 2019-05-22 4 Sharp John P PHAS Common Stock M - Exercise D 1,6900 15 000 25 20 000
2019-05-21 2019-05-20 4 Mow Jonathan P PHAS Employee stock option (right to buy) M - Exercise D 1,24 −19 131 0
2019-05-21 2019-05-20 4 Mow Jonathan P PHAS Common Stock M - Exercise D 1,2400 19 131 24 90 243
2019-05-21 2019-05-17 4 Mow Jonathan P PHAS Employee stock option (right to buy) M - Exercise D 2,27 −19 913 0
2019-05-21 2019-05-17 4 Mow Jonathan P PHAS Common Stock M - Exercise D 2,2700 19 913 45 71 112
2019-05-13 2019-05-09 4 Thorp Clay PHAS Non-employee Director Stock Option (right to buy) A - Award D 13,23 11 000 11 000
2019-05-13 2019-05-09 4 Hutson Nancy J PHAS Non-employee Director Stock Option (right to buy) A - Award D 13,23 11 000 11 000
2019-05-13 2019-05-09 4 Loewy Caroline M PHAS Non-employee Director Stock Option (right to buy) A - Award D 13,23 9 167 9 167
2019-05-13 2019-05-09 4 HARRIGAN EDMUND PHAS Non-employee Director Stock Option (right to buy) A - Award D 13,23 4 583 4 583
2019-05-13 2019-05-09 4 van den Broek Richard PHAS Non-employee Director Stock Option (right to buy) A - Award D 13,23 2 750 2 750
2019-05-13 2019-05-09 4 Klein Peter Justin PHAS Non-employee Director Stock Option (right to buy) A - Award D 13,23 11 000 11 000
2019-05-13 2019-05-09 4 Mukhopadhyay Bibhash PHAS Non-employee Director Stock Option (right to buy) A - Award D 13,23 11 000 11 000
2019-03-01 2019-02-27 4 TUFTS LINDA PHAS Non-employee Director Stock Option (right to buy) A - Award D 3,15 36 000 36 000
2019-03-01 2019-02-27 4 Ballance David James PHAS Employee Stock Option (right to buy) A - Award D 3,15 45 000 45 000
2019-03-01 2019-02-27 4 Hutson Nancy J PHAS Employee Stock Option (right to buy) A - Award D 3,15 8 900 8 900
2019-03-01 2019-02-27 4 Klein Peter Justin PHAS Non-employee Director Stock Option (right to buy) A - Award D 3,15 36 000 36 000
2019-03-01 2019-02-27 4 Lee John Sang PHAS Employee Stock Option (right to buy) A - Award D 3,15 100 000 100 000
2019-03-01 2019-02-27 4 Loewy Caroline M PHAS Non-employee Director Stock Option (right to buy) A - Award D 3,15 8 900 8 900
2019-03-01 2019-02-27 4 Sharp John P PHAS Employee Stock Option (right to buy) A - Award D 3,15 100 000 100 000
2019-03-01 2019-02-27 4 Thorp Clay PHAS Employee Stock Option (right to buy) A - Award D 3,15 36 000 36 000
2019-03-01 2019-02-27 4 van den Broek Richard PHAS Non-employee Director Stock Option (right to buy) A - Award D 3,15 23 000 23 000
2019-03-01 2019-02-27 4 van den Broek Richard PHAS Non-employee Director Stock Option (right to buy) A - Award D 3,15 22 000 22 000
2019-03-01 2019-02-27 4 York Michael PHAS Employee Stock Option (right to buy) A - Award D 3,15 45 000 45 000
2019-03-01 2019-02-27 4 Mukhopadhyay Bibhash PHAS Non-employee Director Stock Option (right to buy) A - Award D 3,15 36 000 36 000
2019-03-01 2019-02-27 4 Mow Jonathan P PHAS Employee Stock Option (right to buy) A - Award D 3,15 263 000 263 000
2019-03-01 2019-02-27 4 Arnold Susan Elizabeth PHAS Employee Stock Option (right to buy) A - Award D 3,15 45 000 45 000
2018-12-17 3/A Ballance David James PHAS Common Stock D 6 600
2018-12-17 2018-12-17 4 Hutson Nancy J Held in an individual retirement account for the benefit of the reporting person PHAS Common Stock P - Purchase I 4,4600 1 000 4 1 000
2018-12-17 2018-12-13 4 Ballance David James PHAS Common Stock P - Purchase D 3,9400 1 000 4 7 600
2018-12-17 2018-12-13 4 HARRIGAN EDMUND PHAS Employee Stock Option (right to buy) A - Award D 3,65 68 966 68 966
2018-12-17 2018-12-13 4 Mow Jonathan P By the Mow Trust dated April 17, 2008 PHAS Common Stock P - Purchase I 3,6900 1 000 4 51 199
2018-12-13 2018-12-10 4/A Mow Jonathan P By the Mow Trust dated April 17, 2008 PHAS Common Stock P - Purchase I 3,8500 800 3 50 199
2018-12-13 2018-12-07 4/A Mow Jonathan P By the Mow Trust dated April 17, 2008 PHAS Common Stock P - Purchase I 3,8900 700 3 49 399
2018-12-11 2018-12-10 4 Mow Jonathan P By the Mow Trust dated April 17, 2008 PHAS Common Stock P - Purchase I 3,8500 800 3 51 699
2018-12-11 2018-12-07 4 Mow Jonathan P By the Mow Trust dated April 17, 2008 PHAS Common Stock P - Purchase I 3,8800 2 200 9 50 899
2018-12-11 2018-12-07 4 Sharp John P PHAS Common Stock P - Purchase D 3,8400 5 000 19 5 000
2018-12-11 2018-12-11 4 York Michael PHAS Common Stock P - Purchase D 3,8800 1 500 6 1 500
2018-12-06 2018-12-04 4 Thorp Clay PHAS Common Stock P - Purchase D 3,1300 4 000 13 15 799
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Series D Preferred Stock C - Conversion I −1 124 301 0
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Series C-1 Preferred Stock C - Conversion I −437 706 0
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Series C-1 Preferred Stock S - Sale I 5,0000 −4 349 −22 437 706
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Series C-1 Preferred Stock X - Other I 0,1200 181 190 22 442 055
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Warrants to Purchase Series C-1 Preferred Stock X - Other I 0,12 −181 190 0
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Series B Preferred Stock C - Conversion I −3 279 627 0
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Series B Preferred Stock S - Sale I 5,0000 −1 177 −6 3 279 627
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Series B Preferred Stock X - Other I 0,1200 49 030 6 3 280 804
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Warrants to Purchase Series B Preferred Stock X - Other I 0,12 −49 030 0
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Common Stock P - Purchase I 5,0000 1 800 000 9 000 6 641 634
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Common Stock C - Conversion I 4 841 634 4 841 634
2018-10-24 2018-10-22 4 Klein Peter Justin PHAS Series B Preferred Stock C - Conversion D −2 303 0
2018-10-24 2018-10-22 4 Klein Peter Justin PHAS Series B Preferred Stock S - Sale D 5,0000 −3 −0 2 303
2018-10-24 2018-10-22 4 Klein Peter Justin PHAS Series B Preferred Stock X - Other D 0,1200 103 0 2 306
2018-10-24 2018-10-22 4 Klein Peter Justin PHAS Warrants to Purchase Series B Preferred Stock X - Other D 0,12 −103 0
2018-10-24 2018-10-22 4 Klein Peter Justin PHAS Common Stock C - Conversion D 2 303 2 303
2018-10-24 2018-10-22 4 Arnold Susan Elizabeth PHAS Series B Preferred Stock C - Conversion D −2 306 0
2018-10-24 2018-10-22 4 Arnold Susan Elizabeth PHAS Series B Preferred Stock M - Exercise D 0,1200 103 0 2 306
2018-10-24 2018-10-22 4 Arnold Susan Elizabeth PHAS Warrants to Purchase Series B Preferred Stock M - Exercise D 0,12 −103 0
2018-10-24 2018-10-22 4 Arnold Susan Elizabeth PHAS Common Stock C - Conversion D 2 306 2 306
2018-10-24 2018-10-22 4 ASTRAZENECA PLC By Zeneca, Inc. PHAS Series D Preferred Stock C - Conversion I −740 337 0
2018-10-24 2018-10-22 4 ASTRAZENECA PLC By Zeneca, Inc. PHAS Series C-1 Preferred Stock C - Conversion I −1 664 217 0
2018-10-24 2018-10-22 4 ASTRAZENECA PLC By Zeneca, Inc. PHAS Series C-1 Preferred Stock S - Sale I 5,0000 −2 734 −14 1 664 217
2018-10-24 2018-10-22 4 ASTRAZENECA PLC By Zeneca, Inc. PHAS Series C-1 Preferred Stock X - Other I 0,1200 113 891 14 1 666 951
2018-10-24 2018-10-22 4 ASTRAZENECA PLC By Zeneca, Inc. PHAS Warrants to Purchase Series C-1 Preferred Stock X - Other I 0,12 −113 891 0
2018-10-24 2018-10-22 4 ASTRAZENECA PLC By Zeneca, Inc. PHAS Common Stock P - Purchase I 5,0000 600 000 3 000 3 004 554
2018-10-24 2018-10-22 4 ASTRAZENECA PLC By Zeneca, Inc. PHAS Common Stock C - Conversion I 2 404 554 2 404 554
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Venture Capital Multiplier Fund PHAS Series D Preferred Stock C - Conversion I −226 061 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Series D Preferred Stock C - Conversion I −24 709 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Series D Preferred Stock C - Conversion I −272 107 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Venture Capital Multiplier Fund PHAS Series C-1 Preferred Stock C - Conversion I −40 420 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Series C-1 Preferred Stock C - Conversion I −13 558 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Series C-1 Preferred Stock C - Conversion I −149 320 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Series B Preferred Stock C - Conversion I −94 874 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Series B Preferred Stock C - Conversion I −1 044 764 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Series AA Preferred Stock C - Conversion I −13 609 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Series AA Preferred Stock C - Conversion I −174 699 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Catalysta Ventures, LLC PHAS Series 1 Preferred Stock C - Conversion I −4 846 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Series 1 Preferred Stock C - Conversion I −3 862 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Series 1 Preferred Stock C - Conversion I −42 530 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners I, LP PHAS Series 1 Preferred Stock C - Conversion I −52 690 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Venture Capital Multiplier Fund PHAS Series C-1 Preferred Stock S - Sale I 5,0000 −994 −5 40 420
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Venture Capital Multiplier Fund PHAS Series C-1 Preferred Stock X - Other I 0,1200 41 414 5 41 414
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Venture Capital Multiplier Fund PHAS Warrants to Purchase Series C-1 Preferred Stock X - Other I 0,12 −41 414 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Series C-1 Preferred Stock S - Sale I 5,0000 −104 −1 13 558
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Series C-1 Preferred Stock X - Other I 0,1200 4 309 1 13 662
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Warrants to Purchase Series C-1 Preferred Stock X - Other I 0,12 −4 309 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Series C-1 Preferred Stock S - Sale I 5,0000 −1 139 −6 149 320
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Series C-1 Preferred Stock X - Other I 0,1200 47 458 6 150 459
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Warrants to Purchase Series C-1 Preferred Stock X - Other I 0,12 −47 458 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Series B Preferred Stock S - Sale I 5,0000 −42 −0 94 874
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Series B Preferred Stock X - Other I 0,1200 1 731 0 94 916
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Warrants to Purchase Series B Preferred Stock X - Other I 0,12 −1 731 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Series B Preferred Stock S - Sale I 5,0000 −458 −2 1 044 764
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Series B Preferred Stock X - Other I 0,1200 19 061 2 1 045 222
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Warrants to Purchase Series B Preferred Stock X - Other I 0,12 −19 061 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Venture Capital Multiplier Fund PHAS Common Stock P - Purchase I 5,0000 150 000 750 416 481
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Venture Capital Multiplier Fund PHAS Common Stock C - Conversion I 266 481 266 481
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Catalysta Ventures, LLC PHAS Common Stock C - Conversion I 4 846 4 846
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Common Stock P - Purchase I 5,0000 12 487 62 163 099
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Common Stock C - Conversion I 150 612 150 612
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Common Stock P - Purchase I 5,0000 137 513 688 1 820 933
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Common Stock C - Conversion I 1 683 420 1 683 420
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners I, LP PHAS Common Stock C - Conversion I 52 690 52 690
2018-10-24 2018-10-22 4 Mow Jonathan P By the Mow Trust dated April 17, 2008 PHAS Series B Preferred Stock C - Conversion I −3 505 0
2018-10-24 2018-10-22 4 Mow Jonathan P PHAS Series B Preferred Stock C - Conversion D −310 0
2018-10-24 2018-10-22 4 Mow Jonathan P PHAS Series B Preferred Stock M - Exercise D 0,1200 310 0 310
2018-10-24 2018-10-22 4 Mow Jonathan P PHAS Warrants to Purchase Series B Preferred Stock M - Exercise D 0,12 −310 0
2018-10-24 2018-10-22 4 Mow Jonathan P By the Mow Trust dated April 17, 2008 PHAS Common Stock C - Conversion I 3 505 48 699
2018-10-24 2018-10-22 4 Mow Jonathan P PHAS Common Stock C - Conversion D 310 310
2018-10-24 2018-10-22 4 Thorp Clay By Venture Capital Multiplier Fund PHAS Series D Preferred Stock C - Conversion I −226 061 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Series D Preferred Stock C - Conversion I −24 709 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Series D Preferred Stock C - Conversion I −272 107 0
2018-10-24 2018-10-22 4 Thorp Clay By Venture Capital Multiplier Fund PHAS Series C-1 Preferred Stock C - Conversion I −40 420 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Series C-1 Preferred Stock C - Conversion I −13 558 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Series C-1 Preferred Stock C - Conversion I −149 320 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Series B Preferred Stock C - Conversion I −94 874 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Series B Preferred Stock C - Conversion I −1 044 764 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Series AA Preferred Stock C - Conversion I −13 609 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Series AA Preferred Stock C - Conversion I −174 699 0
2018-10-24 2018-10-22 4 Thorp Clay By Catalysta Ventures, LLC PHAS Series 1 Preferred Stock C - Conversion I −4 846 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Series 1 Preferred Stock C - Conversion I −3 862 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Series 1 Preferred Stock C - Conversion I −42 530 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners I, LP PHAS Series 1 Preferred Stock C - Conversion I −52 690 0
2018-10-24 2018-10-22 4 Thorp Clay By Venture Capital Multiplier Fund PHAS Series C-1 Preferred Stock S - Sale I 5,0000 −994 −5 40 420
2018-10-24 2018-10-22 4 Thorp Clay By Venture Capital Multiplier Fund PHAS Series C-1 Preferred Stock M - Exercise I 0,1200 41 414 5 41 414
2018-10-24 2018-10-22 4 Thorp Clay By Venture Capital Multiplier Fund PHAS Warrants to Purchase Series C-1 Preferred Stock M - Exercise I 0,12 −41 414 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Series C-1 Preferred Stock S - Sale I 5,0000 −104 −1 13 558
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Series C-1 Preferred Stock M - Exercise I 0,1200 4 309 1 13 662
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Warrants to Purchase Series C-1 Preferred Stock M - Exercise I 0,12 −4 309 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Series C-1 Preferred Stock S - Sale I 5,0000 −1 139 −6 149 320
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Series C-1 Preferred Stock M - Exercise I 0,1200 47 458 6 150 459
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Warrants to Purchase Series C-1 Preferred Stock M - Exercise I 0,12 −47 458 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Series B Preferred Stock S - Sale I 5,0000 −42 −0 94 874
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Series B Preferred Stock M - Exercise I 0,1200 1 731 0 94 916
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Warrants to Purchase Series B Preferred Stock M - Exercise I 0,12 −1 731 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Series B Preferred Stock S - Sale I 5,0000 −458 −2 1 044 764
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Series B Preferred Stock M - Exercise I 0,1200 19 061 2 1 045 222
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Warrants to Purchase Series B Preferred Stock M - Exercise I 0,12 −19 061 0
2018-10-24 2018-10-22 4 Thorp Clay By Venture Capital Multiplier Fund PHAS Common Stock P - Purchase I 5,0000 150 000 750 416 481
2018-10-24 2018-10-22 4 Thorp Clay By Venture Capital Multiplier Fund PHAS Common Stock C - Conversion I 266 481 266 481
2018-10-24 2018-10-22 4 Thorp Clay By Catalysta Ventures, LLC PHAS Common Stock C - Conversion I 4 846 4 846
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Common Stock P - Purchase I 5,0000 12 487 62 163 099
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Common Stock C - Conversion I 150 612 150 612
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Common Stock P - Purchase I 5,0000 137 513 688 1 820 933
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Common Stock C - Conversion I 1 683 420 1 683 420
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners I, LP PHAS Common Stock C - Conversion I 52 690 52 690
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Series D Preferred Stock C - Conversion I −30 334 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Series D Preferred Stock C - Conversion I −6 413 0
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Series D Preferred Stock C - Conversion I −63 688 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Series C-1 Preferred Stock C - Conversion I −22 452 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Series C-1 Preferred Stock C - Conversion I −4 746 0
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Series C-1 Preferred Stock C - Conversion I −47 140 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Series B Preferred Stock C - Conversion I −165 395 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Series B Preferred Stock C - Conversion I −34 968 0
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Series B Preferred Stock C - Conversion I −347 250 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Series AA Preferred Stock C - Conversion I −56 874 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Series AA Preferred Stock C - Conversion I −12 025 0
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Series AA Preferred Stock C - Conversion I −119 408 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Series C-1 Preferred Stock S - Sale I 5,0000 −113 −1 22 452
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Series C-1 Preferred Stock M - Exercise I 0,1200 4 690 1 22 565
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Warrants to Purchase Series C-1 Preferred Stock M - Exercise I 0,12 −4 690 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Series C-1 Preferred Stock S - Sale I 5,0000 −24 −0 4 746
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Series C-1 Preferred Stock M - Exercise I 0,1200 991 0 4 770
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Warrants to Purchase Series C-1 Preferred Stock M - Exercise I 0,12 −991 0
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Series C-1 Preferred Stock S - Sale I 5,0000 −237 −1 47 140
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Series C-1 Preferred Stock M - Exercise I 0,1200 9 847 1 47 377
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Warrants to Purchase Series C-1 Preferred Stock M - Exercise I 0,12 −9 847 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Series B Preferred Stock S - Sale I 5,0000 −81 −0 165 395
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Series B Preferred Stock M - Exercise I 0,1200 3 359 0 165 476
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Warrants to Purchase Series B Preferred Stock M - Exercise I 0,12 −3 359 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Series B Preferred Stock S - Sale I 5,0000 −18 −0 34 968
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Series B Preferred Stock M - Exercise I 0,1200 710 0 34 986
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Warrants to Purchase Series B Preferred Stock M - Exercise I 0,12 −710 0
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Series B Preferred Stock S - Sale I 5,0000 −170 −1 347 250
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Series B Preferred Stock M - Exercise I 0,1200 7 053 1 347 420
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Warrants to Purchase Series B Preferred Stock M - Exercise I 0,12 −7 053 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Common Stock P - Purchase I 5,0000 6 041 30 281 096
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Common Stock C - Conversion I 275 055 275 055
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Common Stock P - Purchase I 5,0000 1 277 6 59 429
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Common Stock C - Conversion I 58 152 58 152
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Common Stock P - Purchase I 5,0000 12 682 63 590 168
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Common Stock C - Conversion I 577 486 577 486
2018-10-17 2018-10-17 4 Mow Jonathan P PHAS Employee Stock Option (right to buy) A - Award D 5,00 220 000 220 000
2018-10-17 3 Thorp Clay PHAS Common Stock D 23 598
2018-10-17 3 Thorp Clay PHAS Common Stock D 23 598
2018-10-17 3 Thorp Clay PHAS Common Stock D 23 598
2018-10-17 3 Mow Jonathan P By the Mow Trust dated April 17, 2008 PHAS Common Stock I 90 388
2018-10-17 3 Mow Jonathan P By the Mow Trust dated April 17, 2008 PHAS Common Stock I 90 388
2018-10-17 3 Mow Jonathan P By the Mow Trust dated April 17, 2008 PHAS Common Stock I 90 388
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista